Incremental cost-effectiveness measures (within trial analysis)
| Probability cost-effective at Rc | ||||||||
|---|---|---|---|---|---|---|---|---|
| Data | Intervention | Cost (£) | ΔCost (£) | QALY | ΔQALY | ICER (ΔCost/ ΔQALY) (£) | £20 000 | £30 000 |
| Complete case* | Standard care | 1486 | 981 | 2.533 | 0.069 | 14 284 | 0.671 | 0.776 |
| Lens extraction | 2467 | 2.602 | ||||||
| Multiple imputation | Standard care | 1567 | 844 | 2.442 | 0.100 | 8430 | 0.885 | 0.940 |
| Lens extraction | 2411 | 2.542 | ||||||
*179 of 285 (93 (64.14%) in the lens extraction and 86 (61.43%) in the standard care group) UK participants have complete cost and QALY data—above regression results are based on the data of these complete cases.
ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life years; Rc, ceiling ratio of willingness to pay per QALY gained.